BNT162b2 Effectiveness Against Delta and Omicron Variants of Severe Acute Respiratory Syndrome Coronavirus 2 in Adolescents Aged 12–17 Years, by Dosing Interval and Duration

BACKGROUND: Two- and 3-dose BNT162b2 vaccine effectiveness (VE) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, including Delta and Omicron variants, was assessed among adolescents in Canada, where first and second doses were spaced longer than the manufacturer-specif...

Descripción completa

Detalles Bibliográficos
Autores principales: Ionescu, Iulia G, Skowronski, Danuta M, Sauvageau, Chantal, Chuang, Erica, Ouakki, Manale, Kim, Shinhye, De Serres, Gaston
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132765/
https://www.ncbi.nlm.nih.gov/pubmed/36645782
http://dx.doi.org/10.1093/infdis/jiad006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132765/
https://www.ncbi.nlm.nih.gov/pubmed/36645782
http://dx.doi.org/10.1093/infdis/jiad006

Ejemplares similares